The ROI of Early Detection Depends on a Program That Doesn’t Break
Every year, a handful of genuinely promising early-detection devices in medtech quietly disappear. Not because the science didn’t work. Because the program didn’t survive long enough to prove that it did. That distinction matters, because it is not how these stories usually get told. When an early-detection platform stalls, the assumption is almost always technical: […]

